We are proud to announce that our latest published collaboration with Pfizer, Wayne State University Karmanos Cancer Institute, University of Wisconsin Carbone Cancer Center, and Rutgers Cancer Institute, has been included in the Best of Journal of Clinical Oncology 2021 Genitourinary Cancer Edition - The title of the publication is "Exploring Spatial-Temporal Changes in 18F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide." The study demonstrates the unique intelligence AIQ technology provides related to intra-patient treatment response heterogeneity and how that heterogeneity impacts patient clinical response.
The AIQ Solutions medical software platform can assist in allowing researchers to understand disease better and clinicians to manage patients more effectively.
For more information on AIQ treatment response solutions
AIQ's software has been cleared for clinical use under 510(k) K173444. For details, including the applicable Indications for Use,